Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERC in Critical Limb Ischemia
NCT01558908Phase 2Unknown
- Sponsor
- Medistem, Inc.
- Start
- May 2012
- Primary completion
- May 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of endometrial regenerative cells in critical limb ischemia (CLI), sponsored by Medistem, Inc.. Status: unknown.
02
Drugs
endometrial regenerative cells
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT01558908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01558908.